Sort
48,018 grants matching “immunotherapy”
Complementary Adenoviral Vectors for Treatment of Cancer
$812,500Magnum Therapeutics · R44 · FY2003 · CA
Nucleoside-modified mRNA vaccine for prevention and treatment of genital herpes
$812,498Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2025 · AI
Nucleoside-modified mRNA vaccine for prevention and treatment of genital herpes
$812,498Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2023 · AI
Nucleoside-modified mRNA vaccine for prevention and treatment of genital herpes
$812,498Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2024 · AI
Pathogenesis of Hepatitis B Virus in Transgenic Mice
$812,392Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2009 · CA
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
$812,211James R. Heath · Institute For Systems Biology · U01 · FY2018 · CA
Mechanisms of CTL Resistance in HIV Reservoirs
$812,001R. Brad Jones · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
SARS-CoV-2 correlates of protection in a Latino-origin population
$812,000Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2024 · CA
Epigenetic Therapy for Thoracic Malignancies
$811,718David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Treg-depleting immunotherapy
$811,405Peter David Suzdak · Sonoval Llc · R44 · FY2022 · CA
Immune Control and Evasion during Acute HCV Infection
$811,256Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2011 · AI
Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease
$810,981Walter J Atwood · Brown University · R35 · FY2024 · NS
Selective B Cell Depletion Using Engineered T Cells As A Curative Treatment For Acquired Thrombotic Thrombocytopenic Purpura
$810,875Vijay Bhoj · University Of Pennsylvania · R01 · FY2025 · HL
Off-the-shelf CAR-Engineered Macrophage Therapy for Alzheimerâs Disease
$810,596Martin Joseph Sadowski · New York University School Of Medicine · R61 · FY2025 · AG
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$810,475Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$810,359Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Vaccine and radiation for the therapy of human cancers
$810,351James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$810,351James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$810,231Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2023 · CA
Multiomic strategies to assess HIV reservoir persistence
$810,146Michael R Betts · University Of Pennsylvania · R01 · FY2023 · AI
Allogeneic glioma vaccine using TGF-beta knockouts
$810,121Habib Fakhrai · Novarx Corporation · R44 · FY2007 · CA
NK/DC Cross-Talk and Antiviral Response
$810,038Luis J. Montaner · Wistar Institute · R01 · FY2009 · AI
PROBING the DYNAMICS of INFANT IMMUNITY to LIMIT HIV PERSISTENCE
$809,993Nancy Logan Haigwood · Oregon Health & Science University · R01 · FY2019 · AI
Immunotherapy for Malignant Mesothelioma
$809,969Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Convergent allergen-specific antibodies in food allergy
$809,948Sarita U Patil · Massachusetts General Hospital · R01 · FY2025 · AI